JUVENILE PSORIATIC ARTHRITIS
Clinical trials for JUVENILE PSORIATIC ARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new JUVENILE PSORIATIC ARTHRITIS trials appear
Sign up with your email to follow new studies for JUVENILE PSORIATIC ARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study checks Long-Term safety of arthritis drug in kids
Disease control Recruiting nowThis study looks at how the body processes secukinumab given through an IV in children aged 2 to 17 with juvenile psoriatic arthritis. Researchers will measure drug levels in the blood and monitor side effects over up to 6 years. The goal is to understand the drug's safety and ho…
Matched conditions: JUVENILE PSORIATIC ARTHRITIS
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 03:17 UTC
-
New hope for kids with arthritis: drug trial aims to stop Flare-Ups
Disease control Recruiting nowThis study tests an oral medication called deucravacitinib in 60 children aged 5 to 17 with active juvenile psoriatic arthritis. The goal is to see if the drug can control the disease and prevent flare-ups. Participants must have tried at least one other treatment without success…
Matched conditions: JUVENILE PSORIATIC ARTHRITIS
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New hope for kids with arthritis? drug trial launches for young patients
Disease control Recruiting nowThis study tests a drug called bimekizumab in children aged 2 to 17 with active juvenile arthritis (enthesitis-related arthritis or juvenile psoriatic arthritis). The goal is to measure how the drug moves through the body and check for side effects. About 40 children will take pa…
Matched conditions: JUVENILE PSORIATIC ARTHRITIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New drug safety check for kids with rare mouth ulcers and arthritis
Disease control Recruiting nowThis study looks at the long-term safety of the drug apremilast in children aged 2 and older with Behçet's disease (which causes painful mouth sores) or aged 5 and older with juvenile psoriatic arthritis (a type of arthritis). About 48 kids who finished a previous study will take…
Matched conditions: JUVENILE PSORIATIC ARTHRITIS
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New arthritis drug trial for kids compares two injection treatments
Disease control Recruiting nowThis study is testing whether a new drug called risankizumab is safe and effective for treating juvenile psoriatic arthritis, a condition where the immune system attacks joints and skin. About 40 children worldwide will receive either risankizumab or an approved drug called adali…
Matched conditions: JUVENILE PSORIATIC ARTHRITIS
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Apr 07, 2026 14:37 UTC